FDA approves first treatment for advanced epithelioid sarcomaJanuary 24, 2020Sarcoma & GISTRare Diseases
T-VEC plus pembrolizumab yields promising response rate in phase 2 sarcoma studyJanuary 24, 2020Sarcoma & GISTImmuno-oncology
Three or more nonadvanced adenomas no longer spell increased CRC riskJanuary 22, 2020GastroenterologyGastrointestinal Cancer
Adding cannabinoids to opioids doesn’t improve cancer pain controlJanuary 22, 2020Patient & Survivor CareOpioid Resource Center
Experts break down latest CAR T-cell advances in lymphomaJanuary 22, 2020Immuno-oncologyImmunotherapyLymphoma & Plasma Cell Disorders
Start of myeloma therapy may be delayed for women, minoritiesJanuary 21, 2020Lymphoma & Plasma Cell Disorders
CAR T-cell therapy may worsen mental health in some patientsJanuary 21, 2020Mixed TopicsLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Medscape survey points to generational differences in physician burnoutJanuary 21, 2020Practice Management
Adult survivors of childhood cancer are experiencing fewer major cardiac eventsJanuary 21, 2020Preventive CareLymphoma & Plasma Cell Disorders
Alan Alda, Scripps Research join forces to improve science communicationJanuary 21, 2020Practice Management
European marketing of Picato suspended while skin cancer risk reviewedJanuary 17, 2020Nonmelanoma Skin Cancer
